Clinical Utility and Gait Analysis of NextAR System AUS
Does Personalized Soft Tissue Balance Data Improve Outcomes in Patients Undergoing Medially Stabilized Knee Arthroplasty? A Prospective, Randomized Study Investigating the Clinical Utility of the NextAR Navigation System (NextAR).
1 other identifier
observational
100
1 country
1
Brief Summary
This study titled "Does Personalised Soft Tissue Balance Data Improve Outcomes in Patients Undergoing Medially Stabilised Arthroplasty? A Prospective, Randomised Study Investigating the Clinical Utility of the NextAR navigation system (NextAR)" is a randomised, single blinded, prospective cohort study with the primary aim determine the clinical utility of the NextAR system data in providing soft tissue balance patterns to enable prosthesis implants to resemble more native knee alignment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2022
CompletedFirst Submitted
Initial submission to the registry
April 26, 2023
CompletedFirst Posted
Study publicly available on registry
May 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedSeptember 29, 2025
September 1, 2025
3 years
April 26, 2023
September 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Determine whether NextAR system data contributes to change patient outcomes using the Forgotten Joint Score
To determine whether NextAR system data contributes to change patient outcomes using the Forgotten Joint Score \- Forgotten Joint Score measures the patient's ability to forget about the joint as a result of successful treatment and is based on the premise that the best arthroplasty is one the patient forgets. This score goes from a minimum of 0 to a maximum of 100 points.
pre-op, 6 weeks, 6 months, 1 year, 2 years
Secondary Outcomes (4)
To determine whether NextAR system data contributes to change patient outcomes using the EQ5D-5L
pre-op, 6 weeks, 6 months, 1 year, 2 years
Determining the kinematics of the replaced knee as measured by 3D gait analysis.
pre-op, 1 year
To determine whether NextAR system data contributes to change patient outcomes using the Oxford Knee Score
pre-op, 6 weeks, 6 months, 1 year, 2 years
To determine whether NextAR system data contributes to change patient outcomes using the Forgotten Joint Score using the International Knee Documentation Committee
pre-op, 6 weeks, 6 months, 1 year, 2 years
Study Arms (2)
control study
patients will be operated with conventional instrumentation
NextAR study
patients will be operated using the NextAR guidance system
Interventions
Implantation of GMK Sphere with conventional instrumentation (control group)
Implantation of GMK Sphere using the NextAR guidance system (NextAR group)
Eligibility Criteria
The trial will include two groups of 50 patients in each group. This is based on a power calculation assuming a difference in Forgotten Join Score of greater than 5 points. This calculation allows for a loss to follow-up of 10%. The study will conclude once the patients involved have completed 2 years of follow-up.
You may qualify if:
- End-stage osteoarthritis of the knee suitable for total knee arthroplasty.
- Aged over 18 years.
You may not qualify if:
- Unsuitable for TKR due to chronic infection, medical disease, inability to consent, inability to attend for post-operative follow-up, significant psychiatric issues, substance abuse issues
- Previous reconstructive/fracture/arthroplasty surgery on affected knee
- Active inflammation arthropathy
- Significant extra articular deformity
- Morbidly Obese (BMI \>40)
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fremantle Hospital
Fremantle, Australia
Study Officials
- PRINCIPAL INVESTIGATOR
Ben Jeffcote
Fremantle Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2023
First Posted
May 18, 2023
Study Start
May 15, 2022
Primary Completion
May 12, 2025
Study Completion
May 1, 2026
Last Updated
September 29, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share